| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.087 | 0.09 |